Scientific Highlights
Basic Science
- Is There Such a Thing as Good Fat?
- Emerging New Players in Metabolic Regulation
- Does GUT Rule? Influence of Microbiome on Diabetes & Obesity
- Clinical Beta Cell Replacement Therapy
- Update on Clinical Trials using Stem Cell Replacement
- Basic Understanding in Lipo-Protein Metabolism
- Control of Glucose Transport by Novel Insulin Signalling Pathway
- Muscle Glucose Metabolism & Mitochondrial Energetics
- Exploring the Interplay of Circadian Rhythm and Exercise
- Maintaining Muscle Mass & Metabolic Health
Diabetes & Co-Morbidity
- Diabetes and the Liver: A Canary in Coal Mine
- The Evolution of CV Outcome Assessment of Antihyperglycemic Medications
- Good, Bad & The Ugly of Lipids in Diabetes
- Obesity in India: Challenges & Strategies for Solutions
- Championing LDL Cholesterol Lowering in Diabetes Care
- Clinical Biomarkers of ASCVD Risk Progression in Diabetes
- Beyond Statins: Treating and Evaluating Residual ASCVD Risk
- Challenging Cases from Cardiometabolic Clinic
Complications of Diabetes
- Systemic Medication for Diabetic Retinopathy
- Many Faces of Kidney Disease in Diabetes: Not all are Diabetic Nephropathy
- Autoimmune Dysfunction: Challenging Clinical Scenarios
- Gastroparesis: Myths & Facts
Diabetes Education
- Diabetes Education for One & for All: Lessons Learned
- Improving Diabetes Care & Outcome through Education
- Possibility of Fasting in Patients with Diabetes
Gestational Diabetes
- Novel Insight into Pathophysiology, Diagnosis & Outcome in GDM
- Novel Approaches to Manage Diabetes in Pregnancy
- Should We Treat Early Gestational Diabetes?
- Early Abnormal Glucose Metabolism in Pregnancy Should be Treated: Yes or No?
Plenary Talks
- How to Say "No" so You can Say Yes: Optimizing Time Management
- Hypoglycemia in Real World: Who's Really at Risk?
- What Does a Person with Diabetes Need from Physician?
- Hyperglycemic Crisis in Diabetes General
- Taking an Obesity Centric Approach to Diabetes Care
- Understanding & Addressing Disparities in Diabetes
- Fighting Diabetes: A Journey that Began in Childhood
- Challenges in Management of Diabetes in Elderly
- Tackling Issue of Diabetes Management in Primary Care
- Big Politics & Little Policy for Diabetes Awareness, Prevention and Management
- How Precision Medicine Changing the Paradigm in Diabetes
- Important Safety Information
- T2DM: What Should be the Focus in 2024?
- Major Advances and Discoveries in Diabetes: The Year in Review - Clinical, Translational & Basic
- Just Do It: Incorporating What We Know into What We Do for Management of Diabetes
Lifestyle & Nutritio
- T2DM & Exercise: Where do We Stand?
- Effect of Dietary Intervention on Insulin Sensitivity
- Does Sucralose Decrease Insulin Sensitivity?
- Does Sucralose Modify Gut Microbiome?
- WHO Said What: Use if Non-Nutritive
- Count Calories or Counting the Hours: Time Restricted Eating
- Protein Quantity, Quality and Timing for Weight Management & Glycemia
- MNT: Moving beyond Traditional Measures
- Impact of Ultra Processed on Metabolic Diseases
Diabetes Prevention
- New Approaches to Prevent or Reverse Diabetes
- Diabetes Prevention: Pressure Points & Future Direction
Diabetes Technology
- Technology Advances & Health Outcome in Diabetes
- Role of CGM for In-Hospital Patient
- How AI Changed Diabetes Clinical Practice?
- Newer Technology in Diabetes Management: What's New?
- Novel Insight from Use of CGM during Pregnancy
- Should CGM be used in GDM?
- Clinical Conversions on CGM
- Early Utilisation of CGM for behavioural Change
- How Soon should AID be Offered?
- Diabetic Retinopathy Care and Screening: Is AI Changing the Future?
- Role of AI in Transforming Nutrition Care for Obesity & Diabetes
- How Effective is CGM to Reduce Hypoglycemia?
- How Diabetes Technology is Changing Diabetes Care in Real world?
Therapeutics
- Inspiring: A New Class of Anti-Diabetes Agent
- SU in T2DM: Should they Stay?
- GLP 1RA v/s Bariatric Surgery: Which Tool is best to Battle the Obesity & Diabetes Epidemics?
- Metformin Re-Examined: In HIP, T1DM, Prevention of T2DM and as First Line Therapy
- GLP-1 Side Effects: GI Upset, Pancreatitis, Thyroid Cancer and Suicidal Risk
- Future Insight of Therapeutics Strategies for Obesity Management
- Placement of DPP4i in Management of Diabetes with CVD
- Multiple Faces of Therapeutic Inertia: Treatment, Hypoglycemia, Lifestyle Counselling & Patient Non-
- Compliance
- Mitochondria as a Therapeutic Target for Diabetes
- Leptin - 30 Years Later: Any Clinical Uses?
- Clinical Implication of Treating Hypercortisolism in Uncontrolled T2DM
- GLP-1 RA in Management of Diabesity
- SGLT2i in Patient with Diabetes & Heart Failure
- Newer Insulin Therapies in Management of Diabetes
- Pioglitazone: Is it Still Relevant?
Type 1 Diabetes
- Lantidra First FDA Approved Therapy to Treat type 1 Diabetes Type 1
- T1DM: Strategies to Improve Awareness & Care for Practicing Clinicians Type 1
- On Insulin Treatment for T1DM Type 1
- Heterogeneity of T1DM Type 1
Therapeutics
- Research Methodology & Medical Writing
- Insulin Pump
- Diabetic Foot